Clinical significance of plasma apolipoprotein F in Japanese healthy and hypertriglyceridemic subjects

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 4, 2013, Pages 380-390

  Kujiraoka, Takeshi ^a   Nakamoto, Takaaki ^b   Sugimura, Hiroyuki ^b   Iwasaki, Tadao ^a   Ishihara, Mitsuaki ^a   Hoshi, Toshiyasu ^b   Horie, Yasuto ^b   Ogawa, Kazuyuki ^a   Todoroki, Masakatsu ^b   Nakatani, Yuki ^b   Banba, Nobuyuki ^b   Yasu, Takanori ^b   Hattori, Hiroaki ^a  

^a Kawagoe shi   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apolipoprotein F; Lipid transfer inhibitory protein; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN F; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCLONAL ANTIBODY; PHOSPHOLIPID TRANSFER PROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CALIBRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HYBRIDOMA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONTENT; PROTEIN EXPRESSION; RADIOACTIVITY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CLONING, ORGANISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; JAPAN; MALE; PHOSPHOLIPID TRANSFER PROTEINS; RECOMBINANT PROTEINS; SEX FACTORS; TRIGLYCERIDES;

EID: 84876837276     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.13706     Document Type: Article

References (28)

1. Wang X, Driscoll DM, Morton RE: Molecular cloning of cholesteryl ester transfer inhibitor protein reveals its identity with apolipoprotein F. J Biol Chem, 1999; 274: 1814-1820
2. Morton RE, Gnizak HM, Greene DJ, Cho K-H, Paromov VM: Lipid transfer inhibitor protein (apolipoprotein F) concentration in noromolipidemic and hyperlipidemic subjects. J Lipid Res, 2008; 49: 127-135
3. Olofsson SO, McConathy WJ, Alaupovic P: Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry, 1978; 17: 1032-1036
4. Day JR, Albers JJ, Gilbert TL, Whitmore TE, McConathy WJ, Wolfbauer G: Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun, 1994; 203: 1146-1151
5. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim Sean, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao X-Q, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW: Shotgun proteomics implicates protease inhibition and complement activation in antiinflammatory properties of HDL. J Clin Invest, 2007; 117: 746-756
6. Koren E, McConathy WJ, Alaupovic P: Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. Biochemistry, 1982; 21: 5347-5351
7. He Y, Greene DJ, Kinter M, Morton RE: Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex. J Lipid Res, 2008; 49: 1529-1537
8. Lagor WR, Brown RJ, Toh SA, Millar JS, Fuki IV, de la Llera-Moya M, Yuen T, Rothblat G, Billheimer JT, Rader DJ: Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo. Arterioscler Thromb Vasc Biol, 2009; 29: 40-46
9. Son YS, Zilversmit DB: Purification and characterization of human plasma proteins that inhibit lipid transfer activities. Biochim Biophys Acta, 1984; 795: 473-480
10. Nishide T, Tollefson JH, Albers JJ: Inhibition of lipid transfer by a unique high density lipoprotein subclass containing an inhibitor protein. J Lipid Res, 1989; 30: 149-158
11. Morton RE: Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. Curr Opin Lipidol, 1999; 10: 321-327
12. Morton RE, Nunes V, Izem L, Quintao E: Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels. Arteroscler Thromb Vasc Biol, 2001; 21: 1642-1649
13. Ishihara M, Kujiraoka T, Iwasaki T, Nagano M, Takano M, Ishii J, Tsuji M, Ide H, Miller IP, Miller NE, Hattori H: A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res, 2005; 46: 2015-2022
14. Kujiraoka T, Oka T, Ishihara M, Egashira T, Fujioka T, Saito E, Saito S, Miller NE, Hattori H: A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration. J Lipid Res, 2000; 41: 1358-1363
15. Kujiraoka T, Iwasaki T, Ishihara M, Ito M, Nagano M, Kawaguchi A, Takahashi S, Ishii J, Tsuji M, Egashira T, Stepanova IP, Miller NE, Hattori H: Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus. J Lipid Res, 2003; 44: 2006-2014
16. Kujiraoka T, Hattori H, Miwa Y, Ishihara M, Ueno T, Ishii J, Tsuji M, Iwasaki T, Sasaguri Y, Fujioka T, Saito S, Tsushima M, Maruyama T, Miller IP, Miller NE, Egashira T: Serum apolipoprotein J in health, coronary heart disease and type 2 diabetes mellitus. J Atheroscler Thromb, 2006; 13: 314-322
17. Gefter ML, Margulies DH, Scharff MD: A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet, 1977; 3: 231-236
18. Nagano M, Yamashita S, Hirano K, Ito M, Maruyama T, Ishihara M, Sagehashi Y, Oka T, Kujiraoka T, Hattori H, Nakajima N, Egashira T, Kondo M, Sakai N, Matasuzawa Y: Two novel missense mutations in the CETP gene in Japanese hyperalphaliporoteinemic subjects: high-throughput assay by Invader® assay. J Lipid Res, 2002; 43: 1011-1018
19. Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, Magnus-Aryitey G, Cosgrove PG, Sand TM, Wester RT, Williams JA, Perlman ME, Bamberger MJ: Raising high-density lipoprotein in humans through inhibition of choelsteryl ester transfer protein: An initial multidose study of Torcetrapib. Arteriscler Thromb Vasc Biol, 2004; 24: 490-497
20. Oka T, Kujiraoka T, Ito M, Nagano M, Ishihara M, Iwasaki T, Egashira T, Miller NE, Hattori H: Measurement of human plasma phsopholipid transfer protein by sandwich ELISA. Clin Chem, 2000; 46: 1357-1364
21. Friedwald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
22. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227: 680-685
23. Towbin T, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA, 1979; 76: 4350-4354
24. McConathy WJ, Alaupovic P: Isolation and characterization of other apolipoproteins. Methods Enzymol, 1986; 128: 297-310
25. Morton RE, Greene DJ: Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition. J Lipid Res, 2011; 52: 2262-2271
26. Nagano M, Yamashita S, Hirano K, Takano M, Maruyama T, Ishihara M, Sagehashi Y, Kujiraoka T, Tanaka K, Hattori H, Sakai N, Nakajima N, Egashira T, Matsuzawa Y: Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J Atheroscler Thromb, 2004; 11: 110-121
27. Oka T, Kujiraoka T, Ito M, Egashira T, Takahashi S, Nanjee MN, Miller NE, Metso J, Olkkonen VM, Ehnholm C, Jauhiainen M, Hattori H: Distribution of phsopholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J Lipid Res, 2000; 41: 1651-1657
28. Korstanje R, Albers JJ, Wolfbauer G, Li R, Tu A-Y, Churchill GA, Paigen BJ: Quantitative trait locus mapping of genes that regulate phospholipid transfer activity in SM/J and NZB/BINJ inbred mice. Arterioscler Thromb Vasc Biol, 2004; 24: 155-160